TransCure bioServices SAS is accredited by the french Ministère de l’Enseignement Supérieur et de la Recherche MESR and the Haut Conseil des Biotechnologies to perform in vivo pharmacology studies for worldwide international customers.
As a preferred provider CRO for our customer’s in vivo pharmacology studies, our team members emphasise competence, transparency, and enthusiasm. We are very pro-active, SOP driven to deliver the best, high quality results you are looking for. Our recognised alliance management skills is appreciated by our clients.
Regarding animal welfare, we apply the strictest regulation in compliance with the national laws of France, guidelines and regulations to underpin our own global bioethical chart:
1 – We are committed to the 3Rs which are, Replacement, Reduction and Refinement, to good science and to the responsible use of animals, which are treated with the highest standards of care and ethics. We only work with highly qualified staffs which are trained regularly in order to ensure the best treatment for research animals. We have started in 2018 the AAALAC accreditation/validation process, and have successfully been audited by large pharma companies since the company creation.
2 – In addition to the inspections by government authorities, we have a formal program of regular peer reviews of our internal animal and laboratory research facilities, conducted by the biopark’s ethical committee and an independent veterinarian.